WASHINGTON (MedPage Today) -- The FDA has approved a new Haemophilus influenzae type b (Hib) vaccine -- Hiberix -- for use as a booster dose from age 15 months through 4 years.
FDA Okays Vaccine for Hib BoosterCourtesy MedPage Today Infectious Disease Thu, 08/20/2009 - 11:47
WASHINGTON (MedPage Today) -- The FDA has approved a new Haemophilus influenzae type b (Hib) vaccine -- Hiberix -- for use as a booster dose from age 15 months through 4 years. More related itemsCDC Reinstates Booster Recommendation for Haemophilus...
FDA Okays Hand-Held Scanner to Spot Clots in Brain
FDA Okays First Cord Blood Product
The Unwritten Rules of Friendship: Simple Strategies...
|
Popular by tags WeekMonth |
Post new comment